State of Wisconsin Investment Board
AST

State of Wisconsin Investment Board’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

State of Wisconsin Investment Board’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,000
Closed -$28K – 1545
2018
Q1 		$28K Hold
19,000
– – ﹤0.01% 1452
2017
Q4 		$43K Hold
19,000
– – ﹤0.01% 1441
2017
Q3 		$65K Hold
19,000
– – ﹤0.01% 1447
2017
Q2 		$67K Buy
+19,000
New +$62.6K ﹤0.01% 1453

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

State of Wisconsin Investment Board's AST Position: Q2 2018 in Review

State of Wisconsin Investment Board sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q2 2018, closing a stake of 19,000 shares — an estimated $28K sold.

State of Wisconsin Investment Board first reported a position in AST in Q2 2017 and held it in 4 quarters. The position peaked at $67K in Q2 2017. 62 funds tracked by Wall St. Rank hold AST as of Q2 2018.

  • State of Wisconsin Investment Board reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q2 2018 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 19,000 Asterias Biotherapeutics Inc. Series A shares in Q2 2018, an estimated $28K.
  • State of Wisconsin Investment Board first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2017 and held it in 4 quarters.
  • State of Wisconsin Investment Board's Asterias Biotherapeutics Inc. Series A position peaked at $67K in Q2 2017.
  • 62 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q2 2018.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2018, filed 3 Aug 2018.